In agreement with our results from the TMA cohorts, assessment of CD68/CD3 ratios in six of the microarray expression cohorts revealed that five cohorts also exhibited a significant trend for worse survival times with higher CD68/CD3 ratios (p for trend <0.05; online supplementary table S12 and figure S9).
← all excerpts
Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas.
1
—
—